Skip to main content
SpringerLink
Log in

JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Campbell PJ, Green AR (2006) The myeloproliferative disorders. N. Engl J Med 355:2652–2666

    Article  Google Scholar 

  2. Tefferi A, Elliott MA (2007) Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F. Semin Thromb Haemost 33:313–320

    Article  CAS  Google Scholar 

  3. Elliott MA, Tefferi A (2005) Thrombosis and Haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 128:275–290

    Article  PubMed  CAS  Google Scholar 

  4. Griesshammer M (2006) Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia. Semin Thromb Hemost 32:372–380

    Article  PubMed  Google Scholar 

  5. Carobbio A, Finazzi G, Guerini V, Spinelli O, Delaini F, Marchioli R, Borrelli G, Rambaldi A, Barbui T (2007) Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood 109:2310–2313

    Article  PubMed  CAS  Google Scholar 

  6. Afshar-Kharghan V, Lopez JA, Gray LA, Padilla A, Borthakur G, Roberts SC, Pruthi RK, Tefferi A (2004) Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia. Blood Coagul Fibrinolysis 15:21–24

    Article  PubMed  CAS  Google Scholar 

  7. Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F (2002) Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. Am J Hematol 71:1–6

    Article  PubMed  CAS  Google Scholar 

  8. Cheung B, Radia D, Pantelidis P, Yadegarfar G, Harrison C (2006) The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia. Br J Haematol 132:244–245

    Article  PubMed  CAS  Google Scholar 

  9. Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, Marfisi RM, Finazzi G, Guerini V, Fabris F, Randi ML, De Stefano V, Caberlon S, Tafuri A, Ruggeri M, Specchia G, Liso V, Rossi E, Pogliani E, Gugliotta L, Bosi A, Barbui T (2007) Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 110:840–846

    Article  PubMed  CAS  Google Scholar 

  10. Besses C, Cervantes F, Pereira A, Florensa L, Sole F, Hernandez-Boluda JC, Woessner S, Sans-Sabrafen J, Rozman C, Montserrat E (1999) Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia 13:150–154

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Murcia, Centro Regional de Hemodonación, C/ Ronda de Garay S/N, Murcia, 30003, Spain

    María J. Moreno, María L. Lozano, V. Roldán, N. García-Barberá, J. Rivera, L. Navarro-Núñez, V. Vicente & C. Martínez

  2. Hospital del Mar, IMAS, Passeig Maritim 25-29, 08003, Barcelona, Spain

    B. Bellosillo & C. Besses

Authors
  1. María J. Moreno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. María L. Lozano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Roldán
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Bellosillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. García-Barberá
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Rivera
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Navarro-Núñez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Besses
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. V. Vicente
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Martínez.

Additional information

This study was supported, in part, by research grants SAF 2004-07535 (MEC) and 03116/PI/05 (Fundación Séneca). L. N-N. is a fellow from Ministerio de Educación y Ciencia (BES-2005-7496). C. M. is Ramón y Cajal investigator from the University of Murcia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno, M.J., Lozano, M.L., Roldán, V. et al. JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia. Ann Hematol 87, 763–765 (2008). https://doi.org/10.1007/s00277-008-0474-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0474-z

Keywords

Search

Navigation